PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM ACHIEVES FIRST REVENUE, page-9

  1. 816 Posts.
    lightbulb Created with Sketch. 379

    I think this bit was a @Mozzarc & 51 Capital shout out!

    - First Revenue albeit small but changes the company in the eyes of investors
    - DMOAD trial ongoing
    - Significant revenue to follow pending further outcomes
    - OA remains the 'holy grail' and focus

    I know its a bit cumbersome for the company but i think ongoing disclosure like this is very good and alleviates any gossip

    https://hotcopper.com.au/data/attachments/3192/3192215-cedc4b97e70669bad2545092a9dbdd3e.jpg
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.